Evonik's Andrea Engel, Ph.D., and Philipp Heller, Ph.D.,m discuss the development of charge-altering releasable transporters (CARTs), polymeric delivery vehicles that capable of delivering many types of nucleic acids and potentially other negatively charged biomolecules that complement lipid nanoparticle delivery.
.svg)
